Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platform

Chem Commun (Camb). 2011 Aug 28;47(32):9176-8. doi: 10.1039/c1cc12961a. Epub 2011 Jul 15.

Abstract

A platform protocol developed based on the hollow manganese oxide nanoparticles provided multimodal diagnostic agents, which allow the selectively detect vulva cancer with T(1)-weighted in vivo MRI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Contrast Media* / chemistry
  • Female
  • Humans
  • Magnetic Resonance Imaging / methods*
  • Manganese Compounds* / chemistry
  • Mice
  • Mice, Inbred BALB C
  • Nanoparticles* / chemistry
  • Nanoparticles* / ultrastructure
  • Oxides* / chemistry
  • Vulvar Neoplasms / diagnosis*

Substances

  • Contrast Media
  • Manganese Compounds
  • Oxides
  • manganese oxide